Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

RX

Biosyent (RX)

Biosyent Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSXV:RX
DatumZeitQuelleÜberschriftSymbolFirma
24/08/202302h22PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:RXBiosyent Inc
16/03/202112h01PR Newswire (Canada)Combogesic® - First Acetaminophen + Ibuprofen Combination Tablet - Now Available for Canadians with Acute PainTSXV:RXBiosyent Inc
16/03/202112h01PR Newswire (Canada)Combogesic(MD) - le premier comprimé associant l'acétaminophène et l'ibuprofène - maintenant disponible pour les Canadien...TSXV:RXBiosyent Inc
25/05/201619h02PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - RXTSXV:RXBiosyent Inc
25/05/201619h00PR Newswire (Canada)IIROC Trading Resumption - RXTSXV:RXBiosyent Inc
25/05/201618h46PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - RXTSXV:RXBiosyent Inc
25/05/201618h44PR Newswire (Canada)IIROC Trading Halt - RXTSXV:RXBiosyent Inc
23/07/201415h43Marketwired CanadaBioSyent Pharma Signs Exclusive Licensing and Distribution Agreement For New Urgent Care Drug ProductTSXV:RXBiosyent Inc
11/07/201423h15PR Newswire (Canada)S&P Dow Jones Indices Announces Quarterly Review of S&P/TSX Venture Select IndexTSXV:RXBiosyent Inc
11/07/201423h15PR Newswire (Canada)Indices S&P Dow Jones annonce les résultats de l'analyse trimestrielle de l'indice sélect S&P/TSX de croissanceTSXV:RXBiosyent Inc
13/06/201423h12MarketwiredBioSyent to Present at the 2014 Bloom Burton & Co. Healthcare Investor ConferenceTSXV:RXBiosyent Inc
13/06/201423h12Marketwired CanadaBioSyent to Present at the 2014 Bloom Burton & Co. Healthcare Investor ConferenceTSXV:RXBiosyent Inc
12/06/201422h01MarketwiredBioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 year Revenue Growth Rate of 608%TSXV:RXBiosyent Inc
12/06/201422h01Marketwired CanadaBioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 year Revenue Growth Rate of 608%TSXV:RXBiosyent Inc
12/06/201414h00MarketwiredBioSyent Pharma Receives Health Canada Approval to Market New Urgent Care ProductTSXV:RXBiosyent Inc
12/06/201414h00Marketwired CanadaBioSyent Pharma Receives Health Canada Approval to Market New Urgent Care ProductTSXV:RXBiosyent Inc
06/06/201414h16MarketwiredBioSyent Annual General Meeting of Shareholders - June 10, 2014TSXV:RXBiosyent Inc
06/06/201414h16Marketwired CanadaBioSyent Annual General Meeting of Shareholders - June 10, 2014TSXV:RXBiosyent Inc
23/05/201414h00MarketwiredBioSyent to Present at the 2014 Marcum MicroCap Investor ConferenceTSXV:RXBiosyent Inc
23/05/201414h00Marketwired CanadaBioSyent to Present at the 2014 Marcum MicroCap Investor ConferenceTSXV:RXBiosyent Inc
21/05/201414h00MarketwiredBioSyent Pharma Launches New RepaGyn® Hormone-Free Vaginal SuppositoriesTSXV:RXBiosyent Inc
21/05/201414h00Marketwired CanadaBioSyent Pharma Launches New RepaGyn® Hormone-Free Vaginal SuppositoriesTSXV:RXBiosyent Inc
16/05/201414h00MarketwiredBioSyent Releases First Quarter 2014 Results-Sales Increase 59%, Net Income After Tax Up 49%TSXV:RXBiosyent Inc
16/05/201414h00Marketwired CanadaBioSyent Releases First Quarter 2014 Results-Sales Increase 59%, Net Income After Tax Up 49%TSXV:RXBiosyent Inc
12/03/201413h00Marketwired CanadaBioSyent Releases Q4 and Full Year 2013 Results: Full Year Sales Increase 55%, Net Income Up 25%, 3 Year CAGR 67%, Q4 Sales I...TSXV:RXBiosyent Inc
12/03/201413h00MarketwiredBioSyent Releases Q4 & Full Year 2013 Results: Full Year Sales Increase 55%, Net Income Up 25%, 3 Year CAGR 67%, Q4 Sales Inc...TSXV:RXBiosyent Inc
04/03/201414h00MarketwiredBioSyent Pharma Signs Exclusive Licence & Distribution Agreement for a New Gastrointestinal Health Product Already Approved b...TSXV:RXBiosyent Inc
04/03/201413h00Marketwired CanadaBioSyent Pharma Signs Exclusive Licence and Distribution Agreement for a New Gastrointestinal Health Product Already Approved...TSXV:RXBiosyent Inc
13/02/201414h00MarketwiredBioSyent Named to the 2014 TSX Venture Top 50(R) Ranking-Only TSX Venture Company to Be Recognized as a Top Performer for the...TSXV:RXBiosyent Inc
13/02/201413h00Marketwired CanadaBioSyent Named to the 2014 TSX Venture Top 50(R) Ranking-Only TSX Venture Company to Be Recognized as a Top Performer for the...TSXV:RXBiosyent Inc
 Showing the most relevant articles for your search:TSXV:RX